ArticleJournal of clinical medicine2021

CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab.

Ciro De Luca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.